Portfolio Company · Operating Co.

Revelio

Healthcare, Biopharma

backed byNew Enterprise Associates

CurrentHealthcare, Biopharma

Revelio

a portfolio company of

New Enterprise Associates

Status on record: Current

Investment year: 2022

PE Firm Index

Who owns Revelio?

Revelio is listed as a current portfolio company of New Enterprise Associates on New Enterprise Associates' own portfolio page. New Enterprise Associates has owned Revelio since 2022, per New Enterprise Associates' portfolio page.

Company Snapshot

Revelio is a Healthcare, Biopharma company. Its owner on record, New Enterprise Associates, is a firm. New Enterprise Associates lists at least 49 companies in the index, 19 of them in Healthcare, Biopharma.

SectorHealthcare, Biopharma

Parent PE firmNew Enterprise Associates

Ownership statusCurrent

WebsiteNot on record

About the owner

New Enterprise Associates

Companies in the index: At least 49

Global venture capital firm investing in technology and healthcare.

Read the New Enterprise Associates profile

Questions about Revelio

Who owns Revelio?

What sector is Revelio in?

Revelio is in Healthcare, Biopharma. Classified from the owner's portfolio label.

What else does New Enterprise Associates own in Healthcare, Biopharma?

New Enterprise Associates lists 18 other Healthcare, Biopharma companies in the index, including Celcuity, Comprehensive Pharmacy Services, Corxel, corxel-b&w and CRISPR Therapeutics.

Sources

New Enterprise Associates' page on Revelio
New Enterprise Associates
https://www.nea.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Revelio and does not provide investment advice.

Other portfolio companies of New Enterprise Associates

6 of 48 shown

Brale

Technology, Fintech

Celcuity

Healthcare, Life Sciences

Cloudflare

Technology, Enterprise

Comprehensive Pharmacy Services

Healthcare, Digital Health

Corxel

Healthcare, Life Sciences

corxel-b&w

Healthcare, Life Sciences

See the full New Enterprise Associates portfolio.

Other Healthcare, Biopharma companies held by New Enterprise Associates

Celcuity Comprehensive Pharmacy Services Corxel corxel-b&w CRISPR Therapeutics Curana Health

Other Healthcare, Biopharma portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

New Enterprise Associates

Status: Current

Investment year: 2022

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.